Cite Filings / TSHA / 0000950170-23-042089
Feed Companies Filings Check
Sign in
10-Q

Quarterly Report

Taysha Gene Therapies, Inc. · Filed 2023-08-14 · Acc 0000950170-23-042089

Documents 1

  • 10-Q Quarterly Report , tsha-20230630.htm

Around this filing

  • 2023-11-14 10-Q Quarterly Report
  • 2023-08-16 4 10% owner bought 16,466,667 shares at $0.90 ($14,820,000)
  • 2023-08-16 4 Director bought 777,778 shares at $0.90 ($700,000)
  • 2023-08-16 4 Chief Executive Officer bought 444,444 shares at $0.90 ($400,000)
  • 2023-08-14 8-K Material agreement · Results of operations · Unregistered share sale · Other events
  • 2023-08-14 10-Q Quarterly Report
  • 2023-05-11 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading tsha-20230630.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…